Jordan Davis Sells 40,000 Shares of Tactile Systems Technology, Inc. (TCMD) Stock
Tactile Systems Technology, Inc. (NASDAQ:TCMD) Director Jordan Davis sold 40,000 shares of Tactile Systems Technology stock in a transaction that occurred on Thursday, December 14th. The stock was sold at an average price of $29.52, for a total transaction of $1,180,800.00. Following the sale, the director now owns 5,006 shares of the company’s stock, valued at approximately $147,777.12. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.
Shares of Tactile Systems Technology, Inc. (NASDAQ TCMD) traded down $0.49 during mid-day trading on Friday, hitting $28.90. 198,700 shares of the stock were exchanged, compared to its average volume of 204,527. The company has a market capitalization of $520.26, a price-to-earnings ratio of 195.93, a PEG ratio of 4.39 and a beta of -0.69. Tactile Systems Technology, Inc. has a twelve month low of $14.37 and a twelve month high of $37.88.
Tactile Systems Technology (NASDAQ:TCMD) last announced its quarterly earnings data on Tuesday, November 7th. The company reported $0.07 EPS for the quarter, topping the Zacks’ consensus estimate of $0.05 by $0.02. The business had revenue of $28.28 million for the quarter, compared to analyst estimates of $27.66 million. Tactile Systems Technology had a net margin of 5.84% and a return on equity of 4.75%. The firm’s revenue for the quarter was up 25.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.01 earnings per share. analysts forecast that Tactile Systems Technology, Inc. will post 0.34 EPS for the current fiscal year.
A number of brokerages recently issued reports on TCMD. BTIG Research cut shares of Tactile Systems Technology from a “buy” rating to a “neutral” rating in a report on Monday, September 18th. Guggenheim began coverage on shares of Tactile Systems Technology in a report on Thursday, October 12th. They set a “buy” rating and a $47.00 price objective for the company. Zacks Investment Research upgraded shares of Tactile Systems Technology from a “hold” rating to a “strong-buy” rating and set a $28.00 price objective for the company in a report on Friday, November 10th. Northland Securities assumed coverage on shares of Tactile Systems Technology in a report on Tuesday, October 17th. They set a “market perform” rating for the company. Finally, Sidoti assumed coverage on shares of Tactile Systems Technology in a research note on Friday, December 8th. They issued a “neutral” rating on the stock. Four research analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $34.25.
Tactile Systems Technology Company Profile
Tactile Systems Technology, Inc is a medical technology company that develops and provides medical devices for the treatment of chronic diseases at home. The Company is a manufacturer and distributor of the Flexitouch and Entre Systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition that is often an unintended consequence of cancer treatment, and the ACTitouch System, a medical device used to treat venous leg ulcers and chronic venous insufficiency.
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.